ScandiDos AB (SDOS) - Total Liabilities
Based on the latest financial reports, ScandiDos AB (SDOS) has total liabilities worth Skr24.31 Million SEK (≈ $2.62 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SDOS net assets growth trend to track the company's year-over-year net asset growth rate.
ScandiDos AB - Total Liabilities Trend (2011–2026)
This chart illustrates how ScandiDos AB's total liabilities have evolved over time, based on quarterly financial data. See ScandiDos AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
ScandiDos AB Competitors by Total Liabilities
The table below lists competitors of ScandiDos AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BACTECH ENVIRONMENT.CORP.
F:0BT1
|
Germany | €4.90 Million |
|
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN
|
USA | $10.33 Million |
|
Archies Limited
NSE:ARCHIES
|
India | Rs602.64 Million |
|
Foresight Autonomous Holdings Ltd ADR
NASDAQ:FRSX
|
USA | $2.92 Million |
|
Nala Digital Commerce Ltd
TA:SEFA
|
Israel | ILA10.28 Million |
|
Ahlada Engineers Limited
NSE:AHLADA
|
India | Rs785.46 Million |
|
KNM Group Bhd
KLSE:7164
|
Malaysia | RM2.55 Billion |
|
Megapower Makmur TBK PT
JK:MPOW
|
Indonesia | Rp38.61 Billion |
Liability Composition Analysis (2011–2026)
This chart breaks down ScandiDos AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of ScandiDos AB.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ScandiDos AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ScandiDos AB (2011–2026)
The table below shows the annual total liabilities of ScandiDos AB from 2011 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-04-30 | Skr24.31 Million ≈ $2.62 Million |
-14.39% |
| 2025-04-30 | Skr28.40 Million ≈ $3.06 Million |
-23.63% |
| 2024-04-30 | Skr37.19 Million ≈ $4.00 Million |
+20.86% |
| 2023-04-30 | Skr30.77 Million ≈ $3.31 Million |
+6.14% |
| 2022-04-30 | Skr28.99 Million ≈ $3.12 Million |
-9.36% |
| 2021-04-30 | Skr31.98 Million ≈ $3.44 Million |
+29.27% |
| 2020-04-30 | Skr24.74 Million ≈ $2.66 Million |
-39.02% |
| 2019-04-30 | Skr40.57 Million ≈ $4.37 Million |
+107.55% |
| 2018-04-30 | Skr19.55 Million ≈ $2.10 Million |
+0.33% |
| 2017-04-30 | Skr19.48 Million ≈ $2.10 Million |
-23.57% |
| 2016-04-30 | Skr25.49 Million ≈ $2.74 Million |
+40.94% |
| 2015-04-30 | Skr18.09 Million ≈ $1.95 Million |
+35.93% |
| 2014-04-30 | Skr13.30 Million ≈ $1.43 Million |
-30.67% |
| 2013-04-30 | Skr19.19 Million ≈ $2.07 Million |
+58.75% |
| 2012-04-30 | Skr12.09 Million ≈ $1.30 Million |
+62.99% |
| 2011-04-30 | Skr7.42 Million ≈ $798.19K |
-- |
About ScandiDos AB
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4… Read more